Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit

University of Göttingen

Status: Unknown

Conditions: Myositis; Vasculitis; Systemic Lupus Erythematosus

Treatments: Other: ICU Care

Study type: Observational

Funder types: Other

Identifiers

NCT04022655

4/8/19

Details and patient eligibility

About

Autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, myositis, or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, may affect multiple organ systems. Occasionally, patients deteriorate acutely requiring advanced care in an intensive care unit (ICU). In an ICU setting, mortality is estimated with scoring systems, such as APACHE or SAPSII. Since there are limited data available on their use in autoimmune diseases, with the current study, we aim to assess the usefulness of these ICU scores and analyze predictors of mortality in this particular group of patients.

Enrollment: 60 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients admitted to the ICU at the University Medical Center Göttingen

Exclusion criteria

• Patients with incomplete or missing data

Trial design

60 participants in 1 patient group

ANCA-associated Vasculitis

Description:

Patients with ANCA-associated vasculitis admitted to the ICU

Treatment:

Other: ICU Care